Header Logo

Connection

Michelle Groome to Humans

This is a "connection" page, showing publications Michelle Groome has written about Humans.
Connection Strength

1,762
  1. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial. Viruses. 2023 08 25; 15(9).
    View in: PubMed
    Score: 0,066
  2. Incidence of febrile seizures and associated factors in children in Soweto, South Africa. S Afr Med J. 2021 Aug 02; 111(8):796-802.
    View in: PubMed
    Score: 0,058
  3. Diarrhoeal diseases in Soweto, South Africa, 2020: a cross-sectional community survey. BMC Public Health. 2021 07 20; 21(1):1431.
    View in: PubMed
    Score: 0,058
  4. Cytokine profiles in children with acute intussusception in South Africa. Cytokine. 2021 10; 146:155639.
    View in: PubMed
    Score: 0,057
  5. Clinical presentation and management of childhood intussusception in South Africa. Pediatr Surg Int. 2021 Oct; 37(10):1361-1370.
    View in: PubMed
    Score: 0,057
  6. Winning the Battle Against Rotavirus Diarrhea…One Step at a Time. J Infect Dis. 2020 10 13; 222(10):1587-1588.
    View in: PubMed
    Score: 0,055
  7. Measuring Rotavirus Vaccine Impact in Sub-Saharan Africa. Clin Infect Dis. 2020 05 23; 70(11):2314-2316.
    View in: PubMed
    Score: 0,053
  8. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa. Clin Infect Dis. 2020 04 10; 70(8):1606-1612.
    View in: PubMed
    Score: 0,053
  9. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2020 07; 20(7):851-863.
    View in: PubMed
    Score: 0,053
  10. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting. Paediatr Int Child Health. 2020 02; 40(1):50-57.
    View in: PubMed
    Score: 0,050
  11. Understanding the full clinical spectrum of childhood diarrhoea in low-income and middle-income countries. Lancet Glob Health. 2019 05; 7(5):e534-e535.
    View in: PubMed
    Score: 0,049
  12. Rotavirus Vaccine: Current Use and Future Considerations. Pediatr Infect Dis J. 2017 07; 36(7):676-678.
    View in: PubMed
    Score: 0,043
  13. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017 08; 17(8):843-853.
    View in: PubMed
    Score: 0,043
  14. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa. Clin Infect Dis. 2016 May 01; 62 Suppl 2:S188-95.
    View in: PubMed
    Score: 0,040
  15. Human metapneumovirus-associated severe acute respiratory illness hospitalisation in HIV-infected and HIV-uninfected South African children and adults. J Clin Virol. 2015 Aug; 69:125-32.
    View in: PubMed
    Score: 0,038
  16. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. Lancet Infect Dis. 2014 Nov; 14(11):1096-1104.
    View in: PubMed
    Score: 0,036
  17. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014 Apr 01; 92(4):238-45.
    View in: PubMed
    Score: 0,034
  18. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health. 2012 Aug; 32(3):140-6.
    View in: PubMed
    Score: 0,031
  19. Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine. Vaccine. 2012 Apr 27; 30 Suppl 1:A173-8.
    View in: PubMed
    Score: 0,030
  20. How Can We Accelerate Maternal Vaccination Globally? Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S11-S12.
    View in: PubMed
    Score: 0,018
  21. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,018
  22. Introducing www.epidemic-em.org: A Collection of Online Resources and Training Materials for Strengthening use of Emergency Operations Centers for Epidemic Response. Disaster Med Public Health Prep. 2024 Feb 23; 18:e48.
    View in: PubMed
    Score: 0,017
  23. Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data. Lancet HIV. 2024 Feb; 11(2):e96-e105.
    View in: PubMed
    Score: 0,017
  24. Vaccine value profile for norovirus. Vaccine. 2023 11 03; 41 Suppl 2:S134-S152.
    View in: PubMed
    Score: 0,017
  25. ABO blood types, but not Secretor or Lewis blood types, influence strength of antibody response to Hepatitis B vaccine in Black South African children. Vaccine. 2023 06 01; 41(24):3617-3626.
    View in: PubMed
    Score: 0,016
  26. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022. J Pediatric Infect Dis Soc. 2023 Apr 18; 12(3):128-134.
    View in: PubMed
    Score: 0,016
  27. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clin Infect Dis. 2023 04 17; 76(8):1468-1475.
    View in: PubMed
    Score: 0,016
  28. Human Metapneumovirus-Associated Hospitalization in HIV-1 Exposed Uninfected and HIV-1 Uninfected Children Less Than 5 Years in South Africa. J Pediatric Infect Dis Soc. 2023 Feb 09; 12(1):53-55.
    View in: PubMed
    Score: 0,016
  29. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023 Mar; 128:102-111.
    View in: PubMed
    Score: 0,016
  30. Diagnostic testing practices for diarrhoeal cases in South African public hospitals. BMC Infect Dis. 2022 Nov 09; 22(1):827.
    View in: PubMed
    Score: 0,016
  31. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun. 2022 10 04; 13(1):5860.
    View in: PubMed
    Score: 0,016
  32. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022 09; 10(9):e1247-e1256.
    View in: PubMed
    Score: 0,016
  33. Undiagnosed comorbidities among individuals hospitalised with COVID-19 in South African public hospitals. S Afr Med J. 2022 08 30; 112(9):747-752.
    View in: PubMed
    Score: 0,016
  34. Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa. S Afr Med J. 2022 05 31; 112(5b):361-365.
    View in: PubMed
    Score: 0,015
  35. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022 05 06; 376(6593):eabn4947.
    View in: PubMed
    Score: 0,015
  36. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
    View in: PubMed
    Score: 0,015
  37. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022 03 05; 399(10328):924-944.
    View in: PubMed
    Score: 0,015
  38. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
    View in: PubMed
    Score: 0,015
  39. TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine. Vaccine. 2021 11 26; 39(48):7028-7035.
    View in: PubMed
    Score: 0,015
  40. In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection. Clin Infect Dis. 2021 08 16; 73(4):e981-e987.
    View in: PubMed
    Score: 0,014
  41. Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013. PLoS One. 2021; 16(8):e0255941.
    View in: PubMed
    Score: 0,014
  42. Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy. Vaccine. 2021 08 09; 39(34):4793-4799.
    View in: PubMed
    Score: 0,014
  43. A decade of rotavirus vaccination in Africa - Saving lives and changing the face of diarrhoeal diseases: Report of the 12th African Rotavirus Symposium. Vaccine. 2021 04 22; 39(17):2319-2324.
    View in: PubMed
    Score: 0,014
  44. Neurological and growth outcomes in South African children with congenital cytomegalovirus: A cohort study. PLoS One. 2020; 15(9):e0238102.
    View in: PubMed
    Score: 0,014
  45. HLA antibody repertoire in infants suggests selectivity in transplacental crossing. Am J Reprod Immunol. 2020 08; 84(2):e13264.
    View in: PubMed
    Score: 0,013
  46. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020 04; 8(4):e497-e510.
    View in: PubMed
    Score: 0,013
  47. Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019 10 30; 69(10):1789-1796.
    View in: PubMed
    Score: 0,013
  48. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019 Sep 25; 8(4):325-333.
    View in: PubMed
    Score: 0,013
  49. Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort. J Crohns Colitis. 2019 Sep 19; 13(9):1111-1120.
    View in: PubMed
    Score: 0,013
  50. The Burden of Acute Diarrheal Disease in Young Hospitalized Urban South African Children Five Years After Rotavirus Vaccine Introduction: A Retrospective Descriptive Study. Pediatr Infect Dis J. 2019 07; 38(7):752-756.
    View in: PubMed
    Score: 0,012
  51. Epidemiology of human astroviruses among children younger than 5 years: Prospective hospital-based sentinel surveillance in South Africa, 2009-2014. J Med Virol. 2019 02; 91(2):225-234.
    View in: PubMed
    Score: 0,012
  52. Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014. Vaccine. 2018 11 12; 36(47):7231-7237.
    View in: PubMed
    Score: 0,011
  53. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017 10; 5(10):e984-e991.
    View in: PubMed
    Score: 0,011
  54. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017 Sep 02; 390(10098):946-958.
    View in: PubMed
    Score: 0,011
  55. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,011
  56. Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. Bull World Health Organ. 2017 Sep 01; 95(9):618-628.
    View in: PubMed
    Score: 0,011
  57. Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017 06 05; 35(25):3303-3308.
    View in: PubMed
    Score: 0,011
  58. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017 06 05; 35(25):3295-3302.
    View in: PubMed
    Score: 0,011
  59. Norovirus epidemiology in South African children <5 years hospitalised for diarrhoeal illness between 2009 and 2013. Epidemiol Infect. 2017 07; 145(9):1942-1952.
    View in: PubMed
    Score: 0,011
  60. Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children. Clin Infect Dis. 2017 02 15; 64(4):443-450.
    View in: PubMed
    Score: 0,011
  61. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011. BMC Pulm Med. 2017 02 02; 17(1):28.
    View in: PubMed
    Score: 0,011
  62. Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South Africa. Pediatr Infect Dis J. 2016 Nov; 35(11):1169-1174.
    View in: PubMed
    Score: 0,010
  63. Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants. Pediatrics. 2016 Apr; 137(4).
    View in: PubMed
    Score: 0,010
  64. Sapovirus prevalence in children less than five years of age hospitalised for diarrhoeal disease in South Africa, 2009-2013. J Clin Virol. 2016 May; 78:82-8.
    View in: PubMed
    Score: 0,010
  65. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,010
  66. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis. 2016 Jan 15; 62(2):157-65.
    View in: PubMed
    Score: 0,010
  67. Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology. PLoS One. 2015; 10(7):e0132078.
    View in: PubMed
    Score: 0,009
  68. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study. Thorax. 2015 Dec; 70(12):1149-55.
    View in: PubMed
    Score: 0,009
  69. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
    View in: PubMed
    Score: 0,009
  70. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015; 10(3):e0118884.
    View in: PubMed
    Score: 0,009
  71. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,009
  72. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis. 2015 Jan 27; 15:26.
    View in: PubMed
    Score: 0,009
  73. Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J. 2015 Jan; 34(1):66-72.
    View in: PubMed
    Score: 0,009
  74. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Vaccine. 2015 Jan 29; 33(5):628-34.
    View in: PubMed
    Score: 0,009
  75. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014 Jul; 20(7):1162-9.
    View in: PubMed
    Score: 0,009
  76. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,009
  77. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S217-26.
    View in: PubMed
    Score: 0,008
  78. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J. 2013 Dec; 32(12):1359-64.
    View in: PubMed
    Score: 0,008
  79. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS One. 2013; 8(8):e72794.
    View in: PubMed
    Score: 0,008
  80. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,008
  81. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
    View in: PubMed
    Score: 0,008
  82. Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J. 2013 May; 32(5):e192-205.
    View in: PubMed
    Score: 0,008
  83. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S159-65.
    View in: PubMed
    Score: 0,008
  84. Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics. 2012 Sep; 130(3):e581-90.
    View in: PubMed
    Score: 0,008
  85. Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J. 2012 Aug; 31(8):821-6.
    View in: PubMed
    Score: 0,008
  86. Epidemiology of acute osteoarticular sepsis in a setting with a high prevalence of pediatric HIV infection. J Pediatr Orthop. 2012 Mar; 32(2):215-9.
    View in: PubMed
    Score: 0,008
  87. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children. J Infect Dev Ctries. 2012 Feb 13; 6(2):109-19.
    View in: PubMed
    Score: 0,007
  88. One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine. S Afr Med J. 2011 Nov 28; 101(12):879-83.
    View in: PubMed
    Score: 0,007
  89. Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2011 Oct; 30(10):e192-202.
    View in: PubMed
    Score: 0,007
  90. Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011 Apr; 30(4):e68-74.
    View in: PubMed
    Score: 0,007
  91. Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.
    View in: PubMed
    Score: 0,007
  92. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009 Dec 05; 374(9705):1909-16.
    View in: PubMed
    Score: 0,006
  93. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009 Jan 03; 373(9657):42-7.
    View in: PubMed
    Score: 0,006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.